Page last updated: 2024-09-03

osw 1 and ER-Negative PR-Negative HER2-Negative Breast Cancer

osw 1 has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Huang, Q; Li, S; Liao, M; Ma, H; Wu, M; Wu, X; Xi, H; Xia, Y; Zhang, Y1
Ding, X; Li, J; Li, Y; Yin, Y1

Other Studies

2 other study(ies) available for osw 1 and ER-Negative PR-Negative HER2-Negative Breast Cancer

ArticleYear
OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis.
    Cellular oncology (Dordrecht), 2022, Volume: 45, Issue:6

    Topics: Animals; Apoptosis; Autophagy; Cell Line, Tumor; Cell Proliferation; Docetaxel; Doxorubicin; Humans; Mice; Phosphatidylinositol 3-Kinases; Triple Negative Breast Neoplasms

2022
OSW-1 inhibits tumor growth and metastasis by NFATc2 on triple-negative breast cancer.
    Cancer medicine, 2020, Volume: 9, Issue:15

    Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cholestenones; Disease Models, Animal; Female; Humans; Mice; Mice, SCID; Neoplasm Metastasis; NFATC Transcription Factors; Ornithogalum; Saponins; Triple Negative Breast Neoplasms

2020